Vyome
India · $47.3M raised
- Business Model
- B2B
- Website
- vyometx.com
- Total Funding
- $47.3M
- Last Round
- $22.0M Series DDec 2018
- Rounds
- 4
About
Vyome Therapeutics is a biopharmaceutical company developing immuno-inflammatory assets for dermatology, focusing on antibiotic-resistant skin conditions.
Summary
Vyome is a Biotech company based in India. It has raised $47.3M in total across 4 rounds, most recently a $22.0M Series D round in Dec 2018. Investors include Iron Pillar, Perceptive Advisors and Sabre Investment.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2018
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...